OIdMIHuOdiu

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia

First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease

Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer